These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12353861)

  • 41. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
    Harris AG
    Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis.
    Hall PA; Coates PJ; Ansari B; Hopwood D
    J Cell Sci; 1994 Dec; 107 ( Pt 12)():3569-77. PubMed ID: 7706406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.
    Chomczynski P
    Biotechniques; 1993 Sep; 15(3):532-4, 536-7. PubMed ID: 7692896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small bowel adaptation: counterregulatory effects of epidermal growth factor and somatostatin on the program of early gene expression.
    Hodin RA; Saldinger P; Meng S
    Surgery; 1995 Aug; 118(2):206-10; discussion 210-1. PubMed ID: 7638735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of somatostatin on growth and differentiation in cultured intestinal mucosa.
    Stange EF; Schneider A; Schusdziarra V; Ditschuneit H
    Horm Metab Res; 1984 Feb; 16(2):74-8. PubMed ID: 6142852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatostatin decreases diarrhea in patients with the short-bowel syndrome.
    Dharmsathaphorn K; Gorelick FS; Sherwin RS; Cataland S; Dobbins JW
    J Clin Gastroenterol; 1982 Dec; 4(6):521-4. PubMed ID: 6131090
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract.
    Lamers CB
    Acta Endocrinol Suppl (Copenh); 1987; 286():19-25. PubMed ID: 2892334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of triamcinolone and somatostatin on morphometric parameters of cultured intestinal mucosa.
    Schneider A; Grösch G; Stange EF; Ditschuneit H
    In Vitro Cell Dev Biol; 1986 Nov; 22(11):647-52. PubMed ID: 2877965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of somatostatin and bombesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat.
    Sagor GR; Ghatei MA; O'Shaughnessy DJ; Al-Mukhtar MY; Wright NA; Bloom SR
    Gut; 1985 Jan; 26(1):89-94. PubMed ID: 2856910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.
    Ladefoged K; Christensen KC; Hegnhøj J; Jarnum S
    Gut; 1989 Jul; 30(7):943-9. PubMed ID: 2668129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine.
    Nightingale JM; Walker ER; Burnham WR; Farthing MJ; Lennard-Jones JE
    Aliment Pharmacol Ther; 1989 Aug; 3(4):367-73. PubMed ID: 2518850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome.
    Rodrigues CA; Lennard-Jones JE; Thompson DG; Farthing MJ
    Aliment Pharmacol Ther; 1989 Apr; 3(2):159-69. PubMed ID: 2491467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats.
    Bass BL; Fischer BA; Richardson C; Harmon JW
    Am J Surg; 1991 Jan; 161(1):107-11; discussion 111-2. PubMed ID: 1987843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sandostatin impairs postresection intestinal adaptation in a rat model of short bowel syndrome.
    Sukhotnik I; Khateeb K; Krausz MM; Sabo E; Siplovich L; Coran AG; Shiloni E
    Dig Dis Sci; 2002 Sep; 47(9):2095-102. PubMed ID: 12353861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal adaptation in short bowel syndrome. What is new?
    Billiauws L; Thomas M; Le Beyec-Le Bihan J; Joly F
    Nutr Hosp; 2018 May; 35(3):731-737. PubMed ID: 29974785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of short bowel syndrome: considerations of resected and residual anatomy.
    Tappenden KA
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):14S-22S. PubMed ID: 24500909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE; Wendel D; Horslen SP
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
    [No Abstract]   [Full Text] [Related]  

  • 58. Intestinal adaptation in short bowel syndrome.
    Welters CF; Dejong CH; Deutz NE; Heineman E
    ANZ J Surg; 2002 Mar; 72(3):229-36. PubMed ID: 12071459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Stem Cell Niche in Short Bowel Syndrome.
    Rubin DC
    Gastroenterol Clin North Am; 2024 Sep; 53(3):473-480. PubMed ID: 39068008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacologic treatment of short bowel syndrome: new tricks and novel agents.
    Bechtold ML; McClave SA; Palmer LB; Nguyen DL; Urben LM; Martindale RG; Hurt RT
    Curr Gastroenterol Rep; 2014; 16(7):392. PubMed ID: 25052938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.